NATIONAL RESEARCH CORP·4

Oct 7, 4:21 PM ET

Jackson Steven D. 4

4 · NATIONAL RESEARCH CORP · Filed Oct 7, 2019

Insider Transaction Report

Form 4
Period: 2019-10-04
Transactions
  • Sale

    Common Stock

    2019-09-25$59.15/sh4,010$237,19589,586 total
Holdings
  • Employee Stock Option (Right to Buy)

    Exercise: $15.23Exp: 2026-01-05Common Stock (21,535 underlying)
    21,535
  • Employee Stock Option (Right to Buy)

    Exercise: $18.80Exp: 2027-01-04Common Stock (17,608 underlying)
    17,608
  • Employee Stock Option (Right to Buy)

    Exercise: $36.80Exp: 2028-01-03Common Stock (12,228 underlying)
    12,228
  • Employee Stock Option (Right to Buy)

    Exercise: $38.30Exp: 2029-01-03Common Stock (11,749 underlying)
    11,749
Footnotes (5)
  • [F1]The price in Column 4 is a weighted average price. The prices actually received ranged from $59.00 to $59.48. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
  • [F2]This option becomes fully exercisable on January 5, 2021.
  • [F3]This option becomes fully exercisable on January 4, 2022.
  • [F4]This option becomes fully exercisable on January 3, 2023.
  • [F5]This option becomes fully exercisable on January 3, 2024.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4